The core product of Wolfman's independent research and development, the intravascular tomography system (OCT), was approved for the first time in March 20 19, and the disposable intravascular imaging catheter was approved in August 20 19, making it a rare enterprise in China to obtain special approval for two innovative medical devices.
Wolfman, founded in September 20 14, is an advanced provider of medical imaging, diagnosis and medical information technology solutions, and is committed to innovative research and development of interventional cardiovascular and cerebrovascular diagnostic instruments and technologies.